美亞光電(002690.SZ)半年度淨利潤預增46.87%-90.93%
格隆匯7月9日丨美亞光電(002690.SZ)公佈,預計2021年半年度歸屬於上市公司股東的淨利潤21650.78萬元-28146萬元,同比增長46.87%-90.93%。業績變動原因如下:
1、報吿期內,隨着國內疫情受控,公司迎來較好的經濟發展環境,公司農產品檢測、高端醫療影像、工業檢測三大板塊業務發展良好,尤其是口腔診療市場的高景氣度對公司高端醫療影像業務的發展產生了積極推動作用。報吿期內,公司口腔CBCT系列產品銷售同比實現大幅增長。
2、報吿期內,公司持續推進“綠色美亞”建設,通過推動智能工廠的高質量運營和管理的數字化升級,公司運營效率不斷提升,對業績產生了一定程度的積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.